Table 3.
Psychosocial and functional characteristics of the study samples
HIV+SCA (n = 24) | HIV+comparison (n = 50) | p Values | Cohen’s d | |
---|---|---|---|---|
Berma | ||||
Memory for medications | 82.8 (11.5) | 73.4 (12.7) | 0.002 | 0.75 |
Dealing with health professionals | 99.2 (13.2) | 91.3 (14.1) | 0.022 | 0.57 |
Attitudes about medications | 37.3 (6.9) | 35.5 (5.9) | 0.272 | 0.29 |
ADL dependence (%) | 12.5% | 40.8% | 0.017 | – |
Unemployed (%) | 65% | 67% | 0.851 | – |
MEMS ART adherencea | 97.5 (6.2) | 89.9 (17.2) | 0.036 | 0.55 |
ART Antiretroviral therapy, BERMA beliefs related to medication adherence, MEMS medication event monitoring system, SCA successful cognitive aging
a n = 16 for HIV+SCA and n = 21 for HIV+comparison group